Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 proposed that intrinsic molecular subtypes of breast cancer can be defined without molecular diagnostics with the help of immunohistochemistry (IHC) for ER, PR, HER2neu and ki67 [9]. This evidence concerns the gene ESR1 and breast carcinoma.